1. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy
   Ming-Chung Jiang, 2016, Tumor Biology CrossRef
2. Identification of new therapeutic targets of bone cancers by proteomic strategies
   Steven L. Wood et al, 2022, Bone Cancer CrossRef
3. CSE1L participates in regulating cell mitosis in human seminoma
   Chunyan Liu et al, 2019, Cell Proliferation CrossRef
4. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing
   Qiang Dong et al, 2018, Proceedings of the National Academy of Sciences CrossRef
5. Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer
   Kerstin Holzer et al, 2017, The American Journal of Pathology CrossRef
6. Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer
   Arjun Gupta et al, 2017, Journal of Thoracic Oncology CrossRef
7. RNA sequencing identified novel target genes forAdansonia digitatain breast and colon cancer cells
   Omar S. El-Masry et al, 2021, Science Progress CrossRef
8. New Insights on Sperm Function in Male Infertility of Unknown Origin: A Multimodal Approach
   Rita I. Pacheco et al, 2023, Biomolecules CrossRef
9. Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors
   Jianni Liu et al, 2019, Medical Oncology CrossRef
10. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer
    Amrita Salvi et al, 2022, Cell Death & Disease CrossRef